NU Skin Enterprises Inc
NYSE:NUS
NU Skin Enterprises Inc
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.
Nu Skin Enterprises, Inc. is a holding company, which engages in the development and distribution of personal care products and nutritional supplements. The company is headquartered in Provo, Utah and currently employs 4,600 full-time employees. Nu Skin develops and distributes beauty and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products that include Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White and Tru Face. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. The firm operates through seven segments, which consists of seven geographic Nu Skin segments, including Mainland China; South Korea; Southeast Asia/Pacific, which includes Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Australia, New Zealand and other markets; Americas, which includes Canada, Latin America and the United States; Japan; Hong Kong/Taiwan, which also includes Macau, and Europe, Middle East and Africa, which includes Europe as well as Israel, Russia and South Africa.
EPS Growth: Nu Skin delivered adjusted EPS of $1.27 for 2025, up 51% from last year and near the high end of original guidance.
Revenue: 2025 revenue was $1.49 billion, within guidance, with Q4 revenue of $370 million and a minor FX headwind.
Margins: Operating margin improved to 6.7% for the year, up 140 basis points, and core Nu Skin gross margin increased by 80 basis points to 77.4%.
Prysm iO Launch: The new Prysm iO intelligent wellness device is rolling out, with a target of 100,000 placements by year-end 2026 and a focus on growing subscription revenue.
India Expansion: Formal India market opening is anticipated for late 2026, with cautious near-term revenue expectations and a focus on local infrastructure.
2026 Guidance: 2026 revenue is projected at $1.35–$1.5 billion, with EPS expected between $0.80 and $1.20 and a higher 35% tax rate.
Shareholder Returns: The company returned $31.8 million to shareholders in 2025 via dividends and share repurchases.
